Skip to content

Clinical trials

Phase 2 Neoplasm Metastasis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Country / region: United Kingdom Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20052
20062
20075
20084
20095
20104
20116
20123
20134
20144
20153
20163
20172
20181
20194
20205
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated13
Active, not recruiting4
Recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer5
AstraZeneca4
Novartis Pharmaceuticals4
European Organisation for Research and Treatment of Cancer - EORTC3
Astellas Pharma Inc2
Clovis Oncology, Inc.2
Daiichi Sankyo2
Pfizer2
Puma Biotechnology, Inc.2
Royal Marsden NHS Foundation Trust2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis65
Breast Neoplasms17
Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Colorectal Neoplasms7
Recurrence5
Prostatic Neoplasms4
Colonic Neoplasms3
Lung Neoplasms3
Ovarian Neoplasms3

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.